Pakistan approves Chinese Sinopharm COVID-19 vaccine for emergency use
Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said. Pakistan's health ministry has said the country was in process of speaking to different vaccine candidates.
Reuters | Islamabad | Updated: 19-01-2021 01:44 IST | Created: 19-01-2021 01:27 IST
Pakistan on Monday approved the Chinese Sinopharm COVID-19 vaccine for emergency use, a government statement said. The Drug Regulatory Authority Pakistan (DRAP) said the vaccine, manufactured by China National Pharmaceutical Group (SinoPharm), had been given emergency use approval (EUA).
The authority had approved AstraZeneca's vaccine, developed with Oxford University, for emergency use at the weekend. Pakistan's health ministry has said the country was in process of speaking to different vaccine candidates.
Advertisement
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
- READ MORE ON:
- AstraZeneca
- Chinese
- Pakistan
- Oxford University
- SinoPharm
Advertisement
ALSO READ
Chinese diplomat blames former Trump administration for U.S.-China difficulties
Chinese ambassador to U.S. says the two countries must define policy boundaries
Chinese blue-chips dip on high valuations, policy tightening fears
Chinese state fund invests in gene firm BGI
Chinese loans to Latin America plunge as virus strains ties